Siemens Healthineers cuts revenue forecast citing diagnostics weakness
Siemens Healthineers cuts revenue forecast citing diagnostics weakness July 31 (Reuters) - Medical technology firm Siemens Healthineers SHLG.DE cut its 2026 revenue growth forecast on Friday to a range of 3.5% to 4.0%, as China's procurement policy weighs on its diagnostics business.
China's volume-based procurement and lower reimbursement rates have depressed prices and sales volumes in the country's diagnostics market.
The German company also raised outlook for adjusted earnings per share to between €2.35 and €2.45, reflecting the amount of U.S. tariff refunds
It had previously forecast annual revenue growth of 5% to 6% and earnings per share in a range of €2.20 to €2.40
Its third-quarter revenue rose 1.8% to €5.76 billion ($6.63 billion) and missed an LSEG consensus estimate by 0.8%
The Erlangen-based firm also posted a year-on-year increase in its adjusted operating profit margin to 19.1% from 16.8%
($1 = 0.8692 euros)
(Reporting by Simon Ferdinand Eibach and Kira Britten, editing by Milla Nissi-Prussak)
((Simonferdinand.eibach@thomsonreuters.com))
Recent news on Siemens Healthineers AG
See all newsSiemens Healthineers forecasts slower 2027 growth as China weakness persists (updated)
Siemens Healthineers seen sliding after 'not good enough' outlook
Siemens Healthineers begins carve-out of diagnostics unit amid China weakness (updated)
Brief: Siemens Healthineers - For FY 2027, Expect Comparable Revenue Growth Between 4.0% And 5.0% Over FY 2026
Siemens Healthineers starts Diagnostics carve-out, names unit Olyrian